Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: UNIVERSITY OF OKLAHOMA
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-09-21 to 2026-05-01
Current total value of award: $910364
Description: EVALUATION OF TWO DIFFERENT CLASSES OF COMPOUNDS (STAT3 INHIBITORS AND SERMS) FOR THE PREVENTION OF URINARY BLADDER CANCER.